No Data
No Data
FTV Capital Expands Internationally With Opening of London Office
As part of the expansion, Richard Earnshaw joins as partner to lead new office and FTV's European investing efforts alongside growing team FTV Capital, a prominent sector-focused growth equity investment firm with a
Morgan Stanley Maintains Enfusion(ENFN.US) With Buy Rating, Maintains Target Price $11
Morgan Stanley analyst Michael Infante maintains $Enfusion(ENFN.US)$ with a buy rating, and maintains the target price at $11.According to TipRanks data, the analyst has a success rate of 0.0% and a t
KKR to Acquire Majority Ownership in Agiloft
Existing investor FTV Capital to invest additional capital in the Company KKR, a leading global investment firm, today announced that a fund managed by KKR has entered into an agreement to acquire a majority stake in
Enfusion To Present at Upcoming Investor Events
Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced that Enfusion's Chief Executive Officer, Oleg Movchan, and Chief
William Blair Maintains Enfusion(ENFN.US) With Buy Rating
William Blair analyst Dylan Becker maintains $Enfusion(ENFN.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 65.6% and a total average return of 5.5% over the past
Buy Rating Affirmed for Enfusion on Strong Growth and Market Positioning Prospects
No Data